CollPlant Biotechnologies (CLGN) Change in Account Payables (2020 - 2025)
Historic Change in Account Payables for CollPlant Biotechnologies (CLGN) over the last 6 years, with Q3 2025 value amounting to $47000.0.
- CollPlant Biotechnologies' Change in Account Payables rose 13643.41% to $47000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$391000.0, marking a year-over-year decrease of 24754.72%. This contributed to the annual value of -$110000.0 for FY2024, which is 2810.46% up from last year.
- Latest data reveals that CollPlant Biotechnologies reported Change in Account Payables of $47000.0 as of Q3 2025, which was up 13643.41% from -$199000.0 recorded in Q2 2025.
- In the past 5 years, CollPlant Biotechnologies' Change in Account Payables registered a high of $253000.0 during Q4 2022, and its lowest value of -$248000.0 during Q1 2023.
- For the 5-year period, CollPlant Biotechnologies' Change in Account Payables averaged around -$9473.7, with its median value being -$19000.0 (2023).
- Examining YoY changes over the last 5 years, CollPlant Biotechnologies' Change in Account Payables showed a top increase of 69523.81% in 2021 and a maximum decrease of 188181.82% in 2021.
- Quarter analysis of 5 years shows CollPlant Biotechnologies' Change in Account Payables stood at $169000.0 in 2021, then soared by 49.7% to $253000.0 in 2022, then decreased by 6.72% to $236000.0 in 2023, then crashed by 158.9% to -$139000.0 in 2024, then skyrocketed by 133.81% to $47000.0 in 2025.
- Its Change in Account Payables stands at $47000.0 for Q3 2025, versus -$199000.0 for Q2 2025 and -$100000.0 for Q1 2025.